CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
@article{Almqvist2016CETSASI, title={CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil}, author={Helena Almqvist and Hanna Axelsson and R. Jafari and Chen Dan and Andr{\'e} Mateus and M. Haraldsson and A. Larsson and Daniel Martinez Molina and P. Artursson and T. Lundb{\"a}ck and P. Nordlund}, journal={Nature Communications}, year={2016}, volume={7} }
Target engagement is a critical factor for therapeutic efficacy. [...] Key Result The screen selected accurately for all the tested known drugs acting on TS. We also identified TS inhibitors with novel chemistry and marketed drugs that were not previously known to target TS, including the DNA methyltransferase inhibitor decitabine. By following the cellular uptake and enzymatic conversion of known drugs we correlated the appearance of active metabolites over time with intracellular target engagement.Expand
Topics from this paper
74 Citations
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
- Chemistry, Medicine
- Vitamins and hormones
- 2018
- 6
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay.
- Chemistry
- 2019
- 20
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
- Medicine
- Science Translational Medicine
- 2019
- 22
- PDF
Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1
- Computer Science, Medicine
- SLAS discovery : advancing life sciences R & D
- 2019
- 10
Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors
- Chemistry, Medicine
- Molecules
- 2019
- 1
- PDF
Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay
- Chemistry, Medicine
- Scientific Reports
- 2017
- 17
- PDF
Chaperone mediated detection of small molecule target binding in cells
- Chemistry, Medicine
- Nature Communications
- 2020
- PDF
CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
- Chemistry, Medicine
- Scientific Reports
- 2017
- 19
- PDF
Evidence of Destabilization of the Human Thymidylate Synthase (hTS) Dimeric Structure Induced by the Interface Mutation Q62R
- Chemistry, Medicine
- Biomolecules
- 2019
- 1
- PDF
Proteochemometric modeling of the origin of thymidylate synthase inhibition
- Chemistry, Medicine
- Chemical biology & drug design
- 2018
- 6
References
SHOWING 1-10 OF 54 REFERENCES
Structure-Guided Development of Deoxycytidine Kinase Inhibitors with Nanomolar Affinity and Improved Metabolic Stability
- Chemistry, Medicine
- Journal of medicinal chemistry
- 2014
- 9
- PDF
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy
- Medicine
- Nature Reviews Clinical Oncology
- 2014
- 228
Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.
- Biology, Medicine
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- 2012
- 282
Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
- Biology, Medicine
- Journal of molecular biology
- 2001
- 52
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- Biology, Medicine
- International journal of cancer
- 2008
- 584
- PDF
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
- Biology, Medicine
- Cancer research
- 1993
- 257
The cellular thermal shift assay for evaluating drug target interactions in cells
- Biology, Medicine
- Nature Protocols
- 2014
- 388
- PDF
5-Fluorouracil: mechanisms of action and clinical strategies
- Biology, Medicine
- Nature Reviews Cancer
- 2003
- 3,239
- PDF